Related Experiment Video
Updated: Feb 9, 2026
06:00
Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection
Published on: December 30, 2025
337
Ischemic Hepatitis - Intercorrelated Pathology
Andrea Olivia Ciobanu1, Leonida Gherasim1
1"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Maedica
|June 6, 2018
Summary
Ischemic hepatitis, often underdiagnosed, stems from severe heart failure or shock. Prompt diagnosis via liver enzymes and hemodynamic monitoring, alongside corrective treatments, improves patient outcomes.
Area of Science:
- Hepatology
- Cardiology
- Critical Care Medicine
Background:
- Ischemic hepatitis is an underdiagnosed condition.
- It commonly occurs in cardiology, hepatology, and intensive care settings.
- Primary causes include severe heart failure, circulatory shock, and septic shock.
Purpose of the Study:
- To highlight the importance of diagnosing ischemic hepatitis.
- To outline diagnostic methods.
- To emphasize the impact of treatment on patient outcomes.
Main Methods:
- Monitoring biological markers such as AST, ALT, and LDH.
- Assessing hemodynamic parameters including blood pressure, cardiac output, and central venous pressure.
- Implementing corrective interventions for hemodynamic instability, hypoxemia, and organ dysfunction.
Main Results:
- Close monitoring of liver enzymes and hemodynamic parameters enables rapid and accurate diagnosis.
- Timely correction of underlying causes and organ dysfunction is crucial.
- Effective management leads to improved patient prognoses.
Conclusions:
- Ischemic hepatitis requires increased clinical recognition.
- Integrated monitoring of biochemical and hemodynamic data is key for diagnosis.
- Multifaceted treatment strategies improve outcomes in patients with ischemic hepatitis.
More Related Videos
Related Concept Videos
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
281
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
01:21Hepatic Portal System
6.1K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.1K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
248
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
248
01:17Ischemic Heart Disease: Overview
3.5K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.5K
01:16Hepatic Drug Excretion: Influencing Factors
597
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
597
01:14Hepatic Drug Clearance: Role of Transporters
311
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
311